claim: an alpaca nanobody neutralizes sars-cov-2 by its receptor interaction
evidence_1: here, we report the isolation and characterization of an alpaca-derived single domain antibody fragment, ty1, that specifically targets the receptor binding domain (rbd) of the sars-cov-2 spike, directly preventing ace2 engagement.